ALSO READAurobindo Pharma recovers after Wednesday's slide Aurobindo Pharma advances after Q4 results Aurobindo Pharma standalone net profit declines 21.41% in the June 2017 quarter Aurobindo Pharma consolidated net profit declines 4.02% in the March 2017 quarter Aurobindo Pharma standalone net profit rises 10.19% in the March 2017 quarter
Sales decline 2.25% to Rs 3621.07 croreNet profit of Aurobindo Pharma declined 11.36% to Rs 518.51 crore in the quarter ended June 2017 as against Rs 584.96 crore during the previous quarter ended June 2016.
Sales declined 2.25% to Rs 3621.07 crore in the quarter ended June 2017 as against Rs 3704.60 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales3621.073704.60 -2 OPM %22.7224.00 -PBDT840.50891.98 -6 PBT709.32785.74 -10 NP518.51584.96 -11
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)